文献速递生殖医学

在诊所常规护理中讨论生育治疗可能不成功:患者的经历、意愿与偏好

Discussing the possibility of fertility treatment being unsuccessful as part of routine care offered at clinics: patients' experiences, willingness, and preferences.
PubMed 文献 · Hum Reprod · 2023-01-01

该横断面混合方法在线调查(英语、葡萄牙语)于2021年4月至2022年1月通过社交媒体发放,分析342名接受IVF/ICSI治疗患者的数据,发现93.3%愿意接受针对治疗不成功的社会心理护理(PCUFT),意愿与更高的感知获益、更低的障碍和更强的积极态度相关。

要点

  • 93.3%的参与者愿意接受针对治疗不成功的社会心理护理(PCUFT)。
  • 78.6%希望由心理学家/精神科医生/咨询师提供PCUFT,73.3%偏好首次周期开始前。
  • 意愿与感知获益更高(OR 3.40)、障碍更低(OR 0.49)、积极态度更强(OR 3.32)相关。

核心结论

  • 生育诊所应在常规护理中尽早提供讨论治疗可能不成功的机会。
  • PCUFT应聚焦于通过 reassurance 患者能够应对任何治疗结果来最小化与悲伤和丧失相关的痛苦,促进应对资源,并指引额外支持。

研究设计与样本

  • 横断面设计,基于理论驱动和以患者为中心的双语(英语、葡萄牙语)混合方法在线调查,于2021年4月至2022年1月通过社交媒体发放。
  • 纳入标准为年龄18岁及以上、等待或正在接受IVF/ICSI周期、或过去6个月内完成周期未获妊娠者;651人访问调查,451人(69.3%)同意参与,342人完成调查(完成率75.8%,338名女性)。

主要发现

  • 参与者平均年龄36岁,多数居住在葡萄牙(59.9%)和英国(38.0%);97.1%处于伴侣关系中约10年,86.3%无子女。
  • 参与者平均接受治疗2年[SD=2.11,范围0-12年],71.8%至少完成过一个IVF/ICSI周期,其中93.5%未成功;34.9%报告接受过PCUFT。
  • 93.3%愿意接受PCUFT;78.6%希望由心理学家/精神科医生/咨询师提供,主要在预后不良(79.4%)、情绪困扰(73.5%)或难以接受治疗可能不成功(71.2%)时。
  • 偏好接受PCUFT的时间为首次周期开始前(73.3%),偏好形式为个体(均值6.37,SD=1.17;1-7量表)或夫妻(均值6.34,SD=1.24;1-7量表)会谈。
  • 接受PCUFT的意愿与感知获益更高(OR 3.40,95%CI 1.23-9.38)、感知障碍更低(OR 0.49,95%CI 0.24-0.98)和积极态度更强(OR 3.32,95%CI 2.12-5.20)相关。

关键数值与推荐

  • 93.3%的参与者愿意接受PCUFT。
  • 78.6%希望由心理学家/精神科医生/咨询师提供PCUFT。
  • 79.4%在预后不良时希望接受PCUFT,73.5%在情绪困扰时,71.2%在难以接受治疗可能不成功时。
  • 73.3%偏好首次周期开始前接受PCUFT。
  • 意愿与感知获益更高(OR 3.40,95%CI 1.23-9.38)、感知障碍更低(OR 0.49,95%CI 0.24-0.98)、积极态度更强(OR 3.32,95%CI 2.12-5.20)相关。

临床怎么用

  • 生育诊所应在常规护理中为患者提供早期机会讨论治疗可能不成功。
  • PCUFT应聚焦于通过 reassurance 患者能够应对任何治疗结果来最小化与悲伤和丧失相关的痛苦,促进应对资源,并指引额外支持。

局限性

  • 自我选择样本,主要由尚未实现父母目标的女性患者组成。
  • 不愿意接受PCUFT的参与者数量少,降低了统计效力。
  • 主要结局变量是意向,研究表明意向与实际行为之间只有中等关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Are patients willing to discuss the possibility of treatment being unsuccessful as part of routine care offered at clinics, and what are the factors associated with this willingness? SUMMARY ANSWER: Nine in every 10 patients are willing to discuss this possibility as part of routine care, with willingness being associated with higher perceived benefits, lower barriers, and stronger positive attitudes towards it. WHAT IS KNOWN ALREADY: Fifty-eight percent of patients who complete up to three cycles of IVF/ICSI in the UK do not achieve a live birth. Offering psychosocial care for unsuccessful fertility treatment (PCUFT), defined as assistance and guidance on the implications of treatment being unsuccessful, could reduce the psychosocial distress patients experience when it happens, and promote positive adjustment to this loss. Research shows 56% of patients are willing to plan for an unsuccessful cycle, but little is known about their willingness and preferences towards discussing the possibility of definitive unsuccessful treatment. STUDY DESIGN, SIZE, DURATION: The study was of cross-sectional design, comprising a theoretically driven and patient-centred bilingual (English, Portuguese) mixed-methods online survey. The survey was disseminated via social media (April 2021-January 2022). Eligibility criteria included being aged 18 or older, waiting to or undergoing an IVF/ICSI cycle, or having completed a cycle within the previous 6 months without achieving a pregnancy. Out of 651 people accessing the survey, 451 (69.3%) consented to participate. From these, 100 did not complete 50% of the survey questions, nine did not report on the primary outcome variable (willingness), and 342 completed the survey (completion rate 75.8%, 338 women). PARTICIPANTS/MATERIALS, SETTING, METHODS: The survey was informed by the Health Belief Model (HBM) and Theory of Planned Behaviour (TPB). Quantitative questions covered sociodemographic characteristics and treatment history. Quantitative and qualitative questions gathered data on past experiences, willingness, and preferences (with whom, what, how and when) to receive PCUFT, as well as theory-informed factors hypothesized to be associated with patients' willingness to receive it. Descriptive and inferential statistics were used on quantitative data about PCUFT experiences, willingness, and preferences, and thematic analysis was applied to textual data. Two logistic regressions were used to investigate the factors associated with patients' willingness. MAIN RESULTS AND THE ROLE OF CHANCE: Participants were, on average, 36 years old and most resided in Portugal (59.9%) and the UK (38.0%). The majority (97.1%) were in a relationship for around 10 years, and 86.3% were childless. Participants were undergoing treatment for, on average, 2 years [SD = 2.11, range: 0-12 years], with most (71.8%) having completed at least one IVF/ICSI cycle in the past, almost all (93.5%) without success. Around one-third (34.9%) reported having received PCUFT. Thematic analysis showed participants received it mainly from their consultant. The main topic discussed was patients' low prognosis, with the emphasis being put on achieving a positive outcome. Almost all participants (93.3%) would like to receive PCUFT. Reported preferences indicated that 78.6% wanted to receive it from a psychologist/psychiatrist/counsellor, mostly in case of a bad prognosis (79.4%), emotional distress (73.5%), or difficulties in accepting the possibility of treatment being unsuccessful (71.2%). The preferred time to receive PCUFT was before initiating the first cycle (73.3%), while the preferred format was in an individual (mean = 6.37, SD = 1.17; in 1-7 scale) or couple (mean = 6.34, SD = 1.24; in 1-7 scale) session. Thematic analysis showed participants would like PCUFT to provide an overview of treatment and all possible outcomes tailored to each patient's circumstances and to encompass psychosocial support, mainly focused on coping strategies to process loss and sustain hope towards the future. Willingness to receive PCUFT was associated with higher perceived benefit of building psychosocial resources and coping strategies (odds ratios (ORs) 3.40, 95% CI 1.23-9.38), lower perceived barrier of triggering negative emotions (OR 0.49, 95% CI 0.24-0.98), and stronger positive attitudes about PCUFT being beneficial and useful (OR 3.32, 95% CI 2.12-5.20). LIMITATIONS, REASONS FOR CAUTION: Self-selected sample, mainly composed of female patients who had not yet achieved their parenthood goals. The small number of participants unwilling to receive PCUFT reduced statistical power. The primary outcome variable was intentions, and research shows a moderate association between intentions and actual behaviour. WIDER IMPLICATIONS OF THE FINDINGS: Fertility clinics should provide patients with early opportunities to discuss the possibility of their treatment being unsuccessful as part of routine care. PCUFT should focus on minimizing suffering associated with grief and loss by reassuring patients they can cope with any treatment outcome, promoting coping resources, and signposting to additional support. STUDY FUNDING/COMPETING INTEREST(S): M.S.-L. holds a doctoral fellowship from the Portuguese Foundation for Science and Technology, I.P. [Fundação para a Ciência e a Tecnologia] (FCT; SFRH/BD/144429/2019). R.C. holds a post-doctoral fellowship supported by the European Social Fund (ESF) and FCT (SFRH/BPD/117597/2016). The EPIUnit, ITR and CIPsi (PSI/01662) are also financed by FCT through the Portuguese State Budget, in the scope of the projects UIDB/04750/2020, LA/P/0064/2020 and UIDB/PSI/01662/2020, respectively. Dr Gameiro reports consultancy fees from TMRW Life Sciences and Ferring Pharmaceuticals A/S, speaker fees from Access Fertility, SONA-Pharm LLC, Meridiano Congress International and Gedeon Richter, grants from Merck Serono Ltd, an affiliate of Merck KgaA, Darmstadt, Germany. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Sousa-Leite M, Costa R, Figueiredo B, et al. Discussing the possibility of fertility treatment being unsuccessful as part of routine care offered at clinics: patients' experiences, willingness, and preferences. Hum Reprod. 2023. PMID: 37196325. doi:10.1093/humrep/dead096

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。